Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles

Nanotechnology

Volumn 19, Issue 26, 2008, Pages

  Pareta, Rajesh A ^a   Taylor, Eric ^b   Webster, Thomas J ^a  

^a Brown University   (United States)

^b The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CALCIUM; CALCIUM PHOSPHATE; CHEMOTHERAPY; COMPUTER NETWORKS; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; ELECTROMAGNETIC FIELD EFFECTS; IRON; MAGNETIC FIELD EFFECTS; MAGNETIC FIELDS; MAGNETIC MATERIALS; MAGNETISM; NANOPARTICLES; NANOSTRUCTURES; OSTEOBLASTS; TISSUE;

BONE CANCER; BONE DENSITY (BD); BONE DISEASES; BONE GROWTH; BONE-FORMING CELLS; DRUG DELIVERY APPLICATIONS; DRUG DELIVERY SYSTEM (DDS); HIGH SPECIFICITY; MAGNETIC (CE); MAGNETIC NANOPARTICLES (MNP'S); OSTEOARTHRITIS (OS); OSTEOPOROSIS (OP); SITE SPECIFIC;

NANOSTRUCTURED MATERIALS;

BOVINE SERUM ALBUMIN; CALCIUM PHOSPHATE; CITRIC ACID; FERRIC OXIDE; MAGNETITE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; BIOCOMPATIBILITY; BONE DISEASE; CELL COUNT; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; MAGNET; MATERIAL COATING; OSTEOBLAST; PARTICLE SIZE; PRIORITY JOURNAL; X RAY DIFFRACTION;

EID: 44949212756     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/19/26/265101     Document Type: Article

References (26)

1. Accessed 14 September 2007 http://www.nof.org/
2. Hughes D E et al 1995 Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo J. Bone Mineral Res. 10 1478-87
3. Hughes D E, MacDonald B R, Rusell R G and Gowen M 1989 Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow J. Clin. Invest. 83 1930-5
4. Reinholz G G et al 2000 Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts Cancer Res. 60 6001-7
5. Adami S and Zamberlan N 1996 The adverse effects of bisphosphonates. A comparative review Drug Safety 14 158-70
6. Update on osteoporosis drugs 2007 [cited 14 September]; available from http://www.health.harvard.edu/newsweek/Update_on_osteoporosis_drugs.htm
7. Accessed 14 September 2007 http://www.health.harvard.edu/newsweek/ Update_on_osteoporosis_drugs.htm
8. Weissleder R, Bogdanov A, Neuwelt E A and Papisov M 1995 Long circulating iron oxides for MR imaging Adv. Drug Deliv. Rev. 16 321-34
9. Berry C C and Curtis A S G 2003 Functionalisation of magnetic nanoparticles for applications in biomedicine J. Phys. D: Appl. Phys. 36 R198-206
10. Gilchrist R K, Medal R, Shorey W D, Hanselman R C, Parrot J C and Taylor C B 1957 Selective inductive heating of lymph nodes Ann. Surg. 146 596-606
11. Schwertmann U and Cornell R M 1991 Iron Oxides in the Laboratory Preparation and Characterization (Cambridge: VCH)
12. Oliveira D M, Lacava Z G M, Lima E C D, Morais P C and Tedesco A C 2006 Zinc phthalocyanine/magnetic fluid complex: a promising dual nanostructured system for cancer treatment J. Nanosci. Nanotechnol. 6 2432-7
13. Thünemann A F, Schütt D, Kaufner L, Pison U and Möhwald H 2006 Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid) Langmiur 22 2351-7
14. Xu C and Sun S 2007 Monodisperse magnetic nanoparticles for biomedical applications Polym. Int. 56 821-6
15. Reimer P and Weissleder R 1996 Development and experimental application of receptor-specific MR contrast media Radiology 36 153-63
16. Chouly C, Pouliquen D, Lucet L, Jeune J J and Jallet P 1996 Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution J. Microencapsul. 13 245-55
17. Gupta P K and Hung C T 1989 Magnetically controlled targeted micro-carrier systems Life Sci. 44 175-86
18. Harris M M et al 2003 Dietary iron is associated with bone mineral density in healthy postmenopausal women J. Nutr. 133 3598-602
19. Parelman M, Stoecker B, Baker A and Medeiros D 2006 Iron restriction negatively affects bone in female rats and mineralization of hFOB osteoblast cells Exp. Biol. Med. 231 378-86
20. Abraham R et al 2006 Dietary determinants of post-menopausal bone loss at the lumbar spine: a possible beneficial effect of iron Osteoporos Int. 17 1165-73
21. Le N and Richardson D R 2004 Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation Blood 104 2967-75
22. 3 particles Chem. Mater. 8 2209-11
23. Gupta A K and Gupta M 2005 Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles Biomaterials 26 1565-73
24. Suchanek W, Yashima M, Kakihana M and Yashimura M 1997 Hydroxyapatite/hydroxyapatite-whisker composites without sintering additives: mechanical properties and microstructural evolution J. Am. Ceram. Soc. 80 2805-13
25. 4 dumbbell nanoparticles as dual-functional probes Angew. Chem. Int. Edn 47 173-6
26. Webster T J, Schadler L S, Siegel R W and Bizios R 2001 Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin Tissue Eng. 7 291-301